Inicio › Cáncer de ovario › Connecticut
Ensayos clínicos de Cáncer de ovario en Connecticut
28 estudios sobre Cáncer de ovario buscan participantes en Connecticut.
Ciudades en Connecticut
- New Haven21 estudios
- East Norwalk10 estudios
- Hartford7 estudios
- Stamford5 estudios
- Bridgeport5 estudios
- Danbury5 estudios
- Norwalk5 estudios
- New London3 estudios
Texto oficial del estudio (inglés)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich
- y 8 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07001748A Study of PHST001 in Advanced Solid Tumors
- Yale Cancer Center, New Haven
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT06840886The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Yale Cancer Center, New Haven
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Yale Cancer Center, New Haven
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06172478Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
- Yale University - Yale University School of Medicine, New Haven
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07360314A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Danbury Hospital, Western Connecticut Health Network /ID# 274783, Danbury
- Yale University School of Medicine /ID# 275794, New Haven
- Norwalk Hospital /ID# 274561, Norwalk
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 29 sept 2026 · NCT06890338A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Site 0158 - Hartford HealthCare, Hartford
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 29 sept 2026 · NCT05128825Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, New Haven
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT05867251A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, New Have
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07229313A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- UConn Health, Farmington
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213804Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Yale University, Yale Cancer Center, New Haven
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05983432FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Yale Cancer Center, New Haven
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT06303505A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0001), New Haven
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 3 sept 2026 · NCT06824467Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
- Danbury Hospital, Danbury
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 1 sept 2026 · NCT07564141A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, New Haven
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07182149A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Danbury Hospital, Danbury
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich
- Hartford Hospital, Hartford
- y 5 más
Reclutando
Edades de 35 a 50 · Mujeres · Actualizado el 7 ago 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Danbury Hospital, Danbury
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich
- y 8 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT06580314A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Yale University School of Medicine, New Haven
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 jul 2026 · NCT06161025A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Norwalk Hospital, Norwalk
ReclutandoFase 2
Edades de 8 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05503797Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
- Yale University, New Haven
Reclutando
Edades de 18 en adelante · Mujeres · Actualizado el 20 jul 2026 · NCT05761561A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
- Yale University, New Haven
ReclutandoFase 1
Edades de 18 en adelante · Mujeres · Actualizado el 6 jul 2026 · NCT07226427Integrated Cancer Repository for Cancer Research
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Yale University, Yale Cancer Center, New Haven
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jun 2026 · NCT06993844Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Hartford Hospital, Hartford
- Smilow Cancer Hospital at Yale- New Haven, New Haven
- Yale University School of Medicine, New Haven
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 16 abr 2026 · NCT05659381A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Yale University, Yale Cancer Center, New Haven
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 mar 2026 · NCT06395519A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- Yale University, New Haven
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 ene 2026 · NCT06234423CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Smilow Cancer Hospital at Yale - New Haven, New Haven
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 23 dic 2025 · NCT06690775SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.